Body weight did not increase from baseline with JANUVIA therapy in either study, compared to a small reduction in patients given placebo
Theyre easy to take, dont require water, and often taste better than traditional supplements
But they are appearing with enough frequency - and consistency - to warrant closer scrutiny
Choose Retatrutide If: Maximum weight loss is the primary goal Previous GLP-1 agonists produced significant nausea (GIP component may help) No specific liver health concerns requiring treatment Tolerance for slightly higher GI side effects during titration Response to dual agonists (like tirzepatide) has been positive Choose Survodutide If: Liver health concerns exist (fatty liver, MASH, elevated liver enzymes) Moderate weight loss goals rather than maximum efficacy priority Interest in potential cardiovascular outcome benefits (CVOT data pending) Preference for a compound with FDA Breakthrough Therapy designation Plans to potentially transition to approved medication once available For most people focused primarily on weight loss, Retatrutide presents the stronger option based on available data
Taken together, the above finding indicates that RAS is involved in stress and that inhibiting RAS reduced the effects of stress
Many individuals in the area face challenges related to lifestyle factors, but with the right support, significant improvements in health are possible
